Patent classifications
G01N33/96
QUANTIFICATION OF PREVIOUSLY UNDETECTABLE QUANTITIES
The present invention centers upon a novel “molecular amplification spike,” which is an admixture of two components, namely, an aliquot of a quantity of a molecule, composition, compound or element of interest (an “analyte”) in its natural isotopic state and an aliquot of an isotopically enriched form of the same molecule, composition, compound or element. The molecular amplification spike contains 20% natural-abundance isotope, balance enriched isotope. The molecular amplification spike may optionally contain more than 20% natural-abundance isotope, with concomitantly reduced balance of enriched isotope. Such an admixed spike, when added to a sample prior to mass spectrometric analysis of that sample, creates new and significantly improved percentage of errors and quantification or confirmation of the absence of the molecule, composition, compound or element of interest in the sample.
Calibrators and controls for the determination of percent glycated hemoglobin in a patient's liquid test sample
Non-limiting embodiments of methodologies for preparing diagnostic assay(s) calibrator(s), calibration material(s), and/or control(s), as well as kits, devices, and method(s) of calibration related thereto.
APPLICATION OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN SENSOR SYSTEMS, DEVICES, AND RELATED METHODS
A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters.
APPLICATION OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN SENSOR SYSTEMS, DEVICES, AND RELATED METHODS
A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters.
Flow Cytometry Measurement Method and Kit for Carrying Out Same
In a flow cytometry measurement method, an analysis medium is provided, which includes a fluid and biological cells contained therein. A labeling molecule is provided and is brought in contact with the analysis medium in such a way that the labeling molecule can bind specifically to a target structure located on the surface of the cell if the cell has said cell structure. For the individual cells, flow cytometry measured values are captured for a first and a second physical parameter. The first parameter is fluorescence radiation emitted by the labeling molecule when the labeling molecule is excited. The cells are classified on the basis of the flow cytometry measured values. A first calibrator and a second calibrator are provided, which have solid particles matching in shape, size and material. A target structure matching the target structure of the cells is immobilized on the surface of the first calibrator. The second calibrator does not have said target structure. The calibrators are mixed with the analysis medium before the flow cytometry measured values are captured. Corresponding first and second flow cytometry measured values are captured for the calibrators as well as for the cells. A normalized first flow cytometry measured value for the cell is formed from the first flow cytometry measured value of the first calibrator, the first flow cytometry measured value of the second calibrator and the first flow cytometry measured value of the cell.
Flow Cytometry Measurement Method and Kit for Carrying Out Same
In a flow cytometry measurement method, an analysis medium is provided, which includes a fluid and biological cells contained therein. A labeling molecule is provided and is brought in contact with the analysis medium in such a way that the labeling molecule can bind specifically to a target structure located on the surface of the cell if the cell has said cell structure. For the individual cells, flow cytometry measured values are captured for a first and a second physical parameter. The first parameter is fluorescence radiation emitted by the labeling molecule when the labeling molecule is excited. The cells are classified on the basis of the flow cytometry measured values. A first calibrator and a second calibrator are provided, which have solid particles matching in shape, size and material. A target structure matching the target structure of the cells is immobilized on the surface of the first calibrator. The second calibrator does not have said target structure. The calibrators are mixed with the analysis medium before the flow cytometry measured values are captured. Corresponding first and second flow cytometry measured values are captured for the calibrators as well as for the cells. A normalized first flow cytometry measured value for the cell is formed from the first flow cytometry measured value of the first calibrator, the first flow cytometry measured value of the second calibrator and the first flow cytometry measured value of the cell.
Methods and systems for providing calibration point acceptance criteria for calibrating an analyte sensor
A method and transceiver for calibrating an analyte sensor using one or more reference measurements. In some embodiments, the method may include receiving a first reference analyte measurement (RM1) and determining whether the RM1 is unexpected. In some embodiments, the method may include, if the RM1 was determined to be unexpected, receiving a second reference analyte measurement (RM2). In some embodiments, the method may include determining whether one or more of the RM1 and the RM2 are acceptable as calibration points. In some embodiments, the method may include, if one or more of the RM1 and the RM2 are determined to be acceptable as calibration points, accepting one or more of the RM1 and the RM2 as calibration points. In some embodiments, the method may include calibrating the analyte sensor using at least one or more of the RM1 and the RM2 as calibration points.
Methods and systems for providing calibration point acceptance criteria for calibrating an analyte sensor
A method and transceiver for calibrating an analyte sensor using one or more reference measurements. In some embodiments, the method may include receiving a first reference analyte measurement (RM1) and determining whether the RM1 is unexpected. In some embodiments, the method may include, if the RM1 was determined to be unexpected, receiving a second reference analyte measurement (RM2). In some embodiments, the method may include determining whether one or more of the RM1 and the RM2 are acceptable as calibration points. In some embodiments, the method may include, if one or more of the RM1 and the RM2 are determined to be acceptable as calibration points, accepting one or more of the RM1 and the RM2 as calibration points. In some embodiments, the method may include calibrating the analyte sensor using at least one or more of the RM1 and the RM2 as calibration points.
Quantification of previously undetectable quantities
The present invention centers upon a novel “molecular amplification spike,” which is an admixture of two components, namely, an aliquot of a quantity of a molecule, composition, compound or element of interest (an “analyte”) in its natural isotopic state and an aliquot of an isotopically enriched form of the same molecule, composition, compound or element. The molecular amplification spike contains 20% natural-abundance isotope, balance enriched isotope. The molecular amplification spike may optionally contain more than 20% natural-abundance isotope, with concomitantly reduced balance of enriched isotope. Such an admixed spike, when added to a sample prior to mass spectrometric analysis of that sample, creates new and significantly improved percentage of errors and quantification or confirmation of the absence of the molecule, composition, compound or element of interest in the sample.
Quantification of previously undetectable quantities
The present invention centers upon a novel “molecular amplification spike,” which is an admixture of two components, namely, an aliquot of a quantity of a molecule, composition, compound or element of interest (an “analyte”) in its natural isotopic state and an aliquot of an isotopically enriched form of the same molecule, composition, compound or element. The molecular amplification spike contains 20% natural-abundance isotope, balance enriched isotope. The molecular amplification spike may optionally contain more than 20% natural-abundance isotope, with concomitantly reduced balance of enriched isotope. Such an admixed spike, when added to a sample prior to mass spectrometric analysis of that sample, creates new and significantly improved percentage of errors and quantification or confirmation of the absence of the molecule, composition, compound or element of interest in the sample.